| 04-27-2011 08:44 AM CET - Health & Medicine |
|
Share of Injectables Supplied in Drug Cartridges Continues to Increase
Press release from: Greystone Research Associates
(Amherst, NH) – In the past two decades, drug delivery has become a major factor in the advancement of the quality of life and a key factor in the business success of pharmaceutical companies. During this time, syringes and injectors have evolved considerably to address the changing demands of clinicians and their patients. In particular, the appearance and refinement of disposable drug cartridges has created unique opportunities for developers of injectable drugs.
Drug cartridges offer several advantages over traditional packaging in vials. For single dose devices, prefilled cartridges contain the exact deliverable dose desired. The custom of overfilling vials to insure availability of the desired dose allows for the possibility of dosing errors that are eliminated with cartridge systems. For recombinant drugs that have an extremely high cost per dose, the economics associated with exact filling are compelling.
As therapeutic markets and patient expectations have evolved, syringes and injectors designed to accept drug cartridges have expanded beyond insulin to a number of growth markets that include immunology, hormone replacement, and reproductive medicine. The convenience and safety of cartridge-based systems relative to traditional syringes will continue to win favor with both clinicians and patients and drive growth at the expense of alternative delivery strategies.
More information on the growing impact of drug cartridge-based Injectables can be found in a new and comprehensive report, researched and prepared by Greystone Research Associates. Drug Cartridge-based Syringes and Injectors: Devices, Therapeutics, Players, Markets and Prospects examines and profiles cartridge-based products, analyzes important therapeutic segments and provides assessments of market participants.
More information is available at www.greystoneassociates.org .
Source: Greystone Research Associates
About Greystone
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Contact:
Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
This release was published on openPR.
Drug cartridges offer several advantages over traditional packaging in vials. For single dose devices, prefilled cartridges contain the exact deliverable dose desired. The custom of overfilling vials to insure availability of the desired dose allows for the possibility of dosing errors that are eliminated with cartridge systems. For recombinant drugs that have an extremely high cost per dose, the economics associated with exact filling are compelling.
As therapeutic markets and patient expectations have evolved, syringes and injectors designed to accept drug cartridges have expanded beyond insulin to a number of growth markets that include immunology, hormone replacement, and reproductive medicine. The convenience and safety of cartridge-based systems relative to traditional syringes will continue to win favor with both clinicians and patients and drive growth at the expense of alternative delivery strategies.
More information on the growing impact of drug cartridge-based Injectables can be found in a new and comprehensive report, researched and prepared by Greystone Research Associates. Drug Cartridge-based Syringes and Injectors: Devices, Therapeutics, Players, Markets and Prospects examines and profiles cartridge-based products, analyzes important therapeutic segments and provides assessments of market participants.
More information is available at www.greystoneassociates.org .
Source: Greystone Research Associates
About Greystone
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Contact:
Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org
This release was published on openPR.
News-ID: 172566
More releases
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
© openPR 2012 | Imprint
More Releases from
Greystone Research Associates
Comments about openPR
I can't but agree to the positive statements about your portal:
easy to use, clear layout, very good search function, and quick editing!
Jens O'Brien, Borgmeier Media Communication
easy to use, clear layout, very good search function, and quick editing!
Jens O'Brien, Borgmeier Media Communication

